1-4 of 4
Thomas Hielscher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma

Juliane L. Buhl, Florian Selt, Thomas Hielscher, Romain Guiho, Jonas Ecker, Felix Sahm, Johannes Ridinger, Dennis Riehl, Diren Usta, Britta Ismer, Alexander C. Sommerkamp, J.P. Martinez-Barbera, Annika K. Wefers, Marc Remke, Daniel Picard, Stefan Pusch, Jan Gronych, Ina Oehme, Cornelis M. van Tilburg, Marcel Kool, Daniela Kuhn, David Capper, Andreas von Deimling, Martin U. Schuhmann, Christel Herold-Mende, Andrey Korshunov, Tilman Brummer, Stefan M. Pfister, David T.W. Jones, Olaf Witt, Till Milde
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1851–1866.
https://doi.org/10.1158/1078-0432.CCR-18-1965
Published: 15 March 2019
View article titled, The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
Open the PDF for The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma in another window
Includes: Supplementary data
Journal Articles

Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Anne Berberich, Tobias Kessler, Carina M. Thomé, Stefan Pusch, Thomas Hielscher, Felix Sahm, Iris Oezen, Lara-Marie Schmitt, Sara Ciprut, Nanina Hucke, Petra Ruebmann, Manuel Fischer, Dieter Lemke, Michael O. Breckwoldt, Andreas von Deimling, Martin Bendszus, Michael Platten, Wolfgang Wick
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 253–265.
https://doi.org/10.1158/1078-0432.CCR-18-1580
Published: 03 January 2019
View article titled, Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
Open the PDF for Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib in another window
Includes: Supplementary data
Journal Articles

Abstract A14: Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

Aoife Ward, Aleksandra Balwierz, Jitao David Zhang, Moritz Kueblbeck, Stefan Wiemann, Thomas Hielscher, Yudi Pawitan, Ozgur Sahin
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): A14.
https://doi.org/10.1158/1078-0432.MECHRES-A14
Published: 04 March 2013
View article titled, Abstract A14: Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Open the PDF for Abstract A14: Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer in another window
Journal Articles

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine

Tobias Meißner, Anja Seckinger, Thierry Rème, Thomas Hielscher, Thomas Möhler, Kai Neben, Hartmut Goldschmidt, Bernard Klein, Dirk Hose
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7240–7247.
https://doi.org/10.1158/1078-0432.CCR-11-1628
Published: 30 November 2011
View article titled, Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine
Open the PDF for Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine in another window
Includes: Supplementary data